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Abstract The galectin-3 gene (LGALS3) encodes a L-galactose
binding lectin. LGALS3 expression is associated with neoplastic
transformation and with differentiation of monocytes to macro-
phages. Factors involved in migration, proliferation, adhesion
and differentiation of vascular smooth muscle cells (SMC) play a
major role during atherosclerosis development. Expression of the
galectin-3 gene was not detected in quiescent SMC but was
activated in aortas of hypercholesterolemic rabbits, in aortas of
rats after balloon injury and in cultured SMC. These results
suggest that galectin-3 production is involved in the develop-
mental process of atherogenesis.
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1. Introduction
Galectin-3, a soluble L-galactoside binding lectin [1], is in-
volved in various biological functions related to cell adhesion,
proliferation and di¡erentiation [2]. Galectin-3 is a non-integ-
rin laminin binding protein [3] and plays a role in cell-cell or
cell-matrix interactions [2]. The production of the lectin is also
related to the proliferative state of di¡erent types of cells [4,5].
It is expressed in a large range of neoplasms and correlates
with the metastatic potential of di¡erent tumors [6^8]. In the
nucleus, it is found associated with hnRNP complexes [9,10]
and has been shown to be necessary for RNA splicing [11].
These observations incited us to investigate the expression
of the LGALS3 (galectin-3) gene in smooth muscle tissues.
Intimal proliferation of vascular smooth muscle cells (SMC)
in the arterial wall is thought to play important roles during
intimal formation and throughout the development of athero-
sclerotic plaques [12,13]. Accumulation of factors resulting in
alteration of proliferation, migration, adhesion and di¡eren-
tiation of SMC may be critical for the evolution of the lesions.
Expression of LGALS3 has been analyzed in vivo in two ex-
perimental models of accelerated atherosclerosis and in vitro
in cultured smooth muscle cells. We present evidence that
LGALS3 is not expressed in normal rabbit and rat arteries.
However, expression of the gene is activated in aorta of hy-
percholesterolemic rabbits and in aorta of rats upon endothe-
lial denudation by balloon catheter injury. Transcription is
also very active in primary cultures of rabbit SMC as well
as in spontaneously immortalized SMC lines. However, in
some SMC lines transformed by herpetic viruses CMV and
HSV-2 expression of LGALS3 appears to be turned o¡. The
mechanism involved in the control of gene expression is in-
dependent of DNA methylation.
2. Materials and methods
2.1. Animals
Hypercholesterolemia was induced by feeding male New Zealand
White rabbits on a cholesterol-rich diet for a period of 6 weeks. The
intima media was separated from the adventitia and endothelium
before RNA extraction. Thoracic aorta of male Wistar rats was me-
chanically injured by three passages of an in£ated embolectomy cath-
eter (Fogarty, size 2F) introduced by the left common carotid artery
under general anesthesia [14]. The animals were killed at varying times
after injury, the aorta was opened longitudinally and the intima media
was dissected free from the adventitia using two pairs of ¢ne forceps.
Samples were removed from several rats and pooled at di¡erent time
points after surgery.
2.2. Cell cultures
Primary cell cultures of SMC from aortas of New Zealand White
rabbits were prepared as described [15]. The Rb-1 line is a SMC
continuous line originating from the aorta of New Zealand rabbits
[16]. Transformed SMC were obtained upon transfection of primary
SMC cultures with plasmids containing the transformed region of
SV40 [15], the morphological transforming region II of herpes simplex
type 2 (HSV-2), [17] or the morphological transforming region of
human cytomegalovirus (CMV) [18].
2.3. cDNA synthesis and PCR (RTPCR)
Total cell RNA (1 Wg), isolated by the guanidinium isothiocyanate
method [19], was reverse transcribed in a reaction mixture containing
8 units of AMV reverse transcriptase (Promega, Madison, WI) and 10
pmol of nonamer random primer. One tenth of the reactions was used
as template for 30 PCR cycles using primers speci¢c for the rabbit and
rat LGALS3 gene, the actin gene or the glyceraldehyde phosphate
dehydrogenase (GAPDH) gene. Primer sequences were: rabbit
LGALS3, upper primer = 5P GTT ATC TGG GTC TGG AAA CC
3P, lower primer = 5P TCT GTT TGC ATT GGG CTT CAC C 3P ; rat
LGALS3, upper primer = 5PGTC ATT GTG TGT AAC ACG AAG
C 3P, lower primer = 5P AGG GTT ATG TCA CCA CTG ATC C 3P ;
actin, upper primer = 5P GCC GGG ACC TGA CCG ACT AC 3P,
lower primer = 5P AGG AAG GAG GGC TGG AAG AG 3P ;
GAPDH upper primer = 5P GGC ACC GTC AAG GCT GAG AA
3P, lower primer = 5P CCA CCA CCC TGT TGC TGT AG 3P. For
quantitative procedures, PCR products were transferred to nylon
membranes and hybridized to 32P-labelled internal oligonucleotides
speci¢c for rat LGALS3 or GAPDH cDNA. Dried gels were scanned
using Phosphorimager (Molecular Dynamics, Sunnyvale, CA). Quan-
ti¢cation of LGALS3 transcripts was evaluated with reference to
GAPDH gene whose expression was constant throughout the experi-
ment. Each sample was assayed in triplicate.
2.4. Southern and Northern blot analysis
DNA and RNA extractions, gel electrophoreses, and transfer to
nylon membranes were performed according to standard techniques
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[20]. 20 Wg of digested cellular DNA and 20 Wg glyoxylated RNA
were analyzed. Hybridization was performed as described [20] using
LGALS3 cDNA or genomic DNA probes. DNA methylation
was analyzed using MspI, a restriction enzyme sensitive to
methylation of the outside cytosine in the sequence CCGG and HpaII
sensitive to methylation of the internal cytosine in the same se-
quence.
2.5. Transfections and luciferase assays
The plasmid pPG3.10 contains about 10 kb of the 5P-£anking re-
gion of rabbit LGALS3 fused to the luciferase gene coding sequence
[21]. pSV2-Luc, a plasmid in which the luciferase gene is driven by the
SV40 early promoter [22], was used as a positive control for luciferase
expression. Plasmid pSV-LGal (Promega, Madison, WI, USA) con-
tained the L-galactosidase gene under the control of SV40 promoter
and enhancer elements. This plasmid was included in each transfec-
tion assay and used as an internal standard of e⁄ciency and reprodu-
cibility. Plasmids were transfected according to Midoux et al. [23].
Brie£y, 106 cells were incubated for 4 h in DMEM containing 100
WM chloroquine, 2 Wg of pSV-LGal and 5 Wg of pPG3.10 or pSV2-Luc
plasmid DNA complexed with 12 Wg lactosylated poly-L-lysine. Cells
were maintained in fresh DMEM supplemented with 10% SVF for 48
h after transfection. Luciferase was assayed using an automated lu-
minometer (Berthold Lumat LB 9501, Colombes, France). L-Galacto-
sidase was assayed as previously described [21].
3. Results
3.1. Detection of LGALS3 transcripts in aortas from normal or
hypercholesterolemic rabbits
Media from aortas of both normal rabbits and cholesterol
fed rabbits were analyzed for the presence of LGALS3 tran-
scripts. Because of the low amounts of RNA available, RT-
PCR was used. In normal aortas, no signal was detected when
ampli¢cation was conducted with LGALS3 primers. Con-
versely, speci¢c transcripts were detected when actin and
GAPDH primers were used (Fig. 1). In aortas from hyper-
cholesterolemic rabbits a signal speci¢c for LGALS3 tran-
scripts was detected. Although no quanti¢cation can be
done on this type of experiment, it appeared clearly that
LGALS3 was not expressed in the media from normal rabbit
aortas but was induced in the intima media of hypercholester-
olemic rabbit aortas. The LGALS3 transcripts detected in
aorta from hypercholesterolemic rabbits could be the result
of expression in macrophages and/or SMC which are the
main types of cells in these lesions.
3.2. Expression of LGALS3 after thoracic aorta angioplasty
Balloon catheter injury of rat thoracic aorta induces acti-
vation, migration and proliferation of SMC leading to ¢bro-
muscular thickening of the intima [13,14]. The aortas were
analyzed at di¡erent times after surgery and transcription of
LGALS3 was followed by RT-PCR (Fig. 2). Only a minimal
background level of LGALS3 mRNA could be detected in
non-injured aortas con¢rming the previous observations on
control rabbit aortas. However, following injury, LGALS3
transcripts were clearly present. Transcription reached a pla-
teau 14^28 days after injury corresponding to maximal thick-
ening of the intima, suggesting that activated SMC can induce
transcription of LGALS3.
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Fig. 1. Detection of LGALS3 transcripts in aortas from normal and
hypercholesterolemic rabbits. RNA from media of aortas from rab-
bits on a normal diet (lanes 2 and 4) or a cholesterol-rich diet (lanes
1 and 3) were analyzed by RT-PCR for the presence of LGALS3
transcripts. PCR fragments were loaded on 1.5% agarose gels.
LGALS3 transcripts were coampli¢ed with GAPDH (lanes 1 and 2)
or with actin (lanes 3 and 4). The expected sizes for LGALS3, actin,
GAPDH fragments are 396 bp, 256 bp and 800 bp respectively.
Lane M is a molecular weight marker.
Fig. 2. Expression of LGLAS3 after angioplasty of rat aortas.
Thoracic aortas were subjected to injury with a balloon catheter. In-
tima media was analyzed at di¡erent time points after injury (x-
axis; 0 stands for uninjured control aorta). LGALS3 transcripts
were analyzed by quantitative RT-PCR. Amount of transcripts was
standardized against the amount of GAPDH transcripts.
Fig. 3. Northern blot analysis of LGALS3 transcripts in cultured
rabbit smooth muscle cells. A: Northern blots of total RNA were
probed with a LGALS3 cDNA. Lane 1: cultures of primary SMC;
lane 2: Rb-1, a spontaneously immortalized SMC line; lane 3:
RCMV-5, a continuous SMC lines obtained upon transfection of
transforming region I of CMV; lane 4: RBC-16, a continuous SMC
lines obtained upon transfection of transforming region II of HSV-
2; lanes 5 and 6: LSV3-4, LSV3-9, SV40 transformed cell lines. B:
In£uence of serum concentration on LGALS3 expression. Rb-1
(lane 1), RCMV-5 (lane 2), RBC-16 (lane 3), and LSV3-4 (lane 4)
were cultivated in medium containing 0.2% serum (lanes 3) or 10%
serum (lanes +).
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3.3. Detection of LGALS3 transcripts in rabbit cultured smooth
muscle cells
Northern blot analysis was performed on RNA isolated
from di¡erent sources of SMC and probed with a LGALS3
cDNA (Fig. 3A). Primary cultures of SMC from rabbit aor-
tas, harvested after two passages, as well as the spontaneously
immortalized rabbit SMC line Rb-1 [16] were found to tran-
scribe the gene actively. All SV40 transformed SMC were also
positive although expressing variable amounts of LGALS3
transcripts. In most of the cell lines transformed by the mor-
phological transforming region of herpetic viruses (CMV and
HSV-2), the amount of LGALS3 mRNA was comparable to
that detected in Rb-1 cells (data not shown). However, in two
of these lines, RCMV-5 and RBC-16, LGALS3 mRNA was
not detected (Fig. 3A) even using RT-PCR (data not shown).
It appeared to be a stable trait and was not modi¢ed after
repeated passages. Equal loading of total RNA on gels for
Northern blot analysis was checked by probing the ¢lters for
L and Q actin transcripts (data not shown).
It has been reported that, in ¢broblasts, the level of expres-
sion of galectin-3 was dependent on the proliferative state of
the cells [24]; in quiescent cells galectin-3 was at a low level
while upon stimulation by adding serum in the culture me-
dium, cells expressed large amounts of galectin-3. In the case
of SMC, no signi¢cant di¡erences in LGALS3 transcripts ap-
peared when adding 0.2% or 10% serum to the culture me-
dium (Fig. 3B). These results indicate that while LGALS3 was
not expressed in quiescent SMC of the media of normal ar-
teries, it could be activated in cultured SMC. This expression
appeared to be constitutive and independent of serum factors.
3.4. Transfection of LGALS3 in expressing and non-expressing
cell lines
Di¡erential expression of LGALS3 in SMC may be surpris-
ing considering that the cell lines have the same lineage. No
di¡erence could be evidenced in the gene structure in South-
ern blot analysis (data not shown). Both expressing (Rb-1)
and non-expressing (RCMV-5) lines are able to activate a
reporter gene under the control of the regulatory region of
LGALS3 in transfection experiments (Fig. 4). This result in-
dicates that transcription factors are present in both cell types
and that sequences responsible for the di¡erential expression
are not present or not functional in the genomic region 310
kb/+112 bp. The possibility of a repressor acting on a ge-
nomic region not present in the reporter plasmid cannot be
excluded. Alternatively, DNA methylation could be involved
in this di¡erential regulation. Methylation was analyzed, by
Southern blotting, on MspI/HpaII sites upstream of the tran-
scription initiation sites in Rb-1 and RCMV-5 DNA (Fig. 5).
A di¡erence in sensitivity of hybridization was detected even
when using PvuII, an enzyme not sensitive to site methylation.
However, no di¡erence could be detected in the banding pat-
tern of these expressing and non-expressing cell lines. For
both lines, the restriction sites immediately upstream of the
transcription sites in the GC rich region of the promoter were
unmethylated while sites located more upstream of this region
were methylated. This indicates that methylation pattern of
DNA was identical in the regulatory region of LGALS3 in
these cell lines.
4. Discussion
A hallmark of atherosclerosis is proliferation and migration
of smooth muscle cells in the arterial intima. While expression
of LGALS3 is frequently enhanced in lesions involving cell
proliferation, no studies have been conducted, to our knowl-
edge, to investigate its expression in SMC of the normal and
pathological arterial wall. No speci¢c transcripts for LGALS3
could be detected in media of aortas from normocholestero-
lemic rabbits but were easily evidenced by RT-PCR analysis
in lesions of aortas from hypercholesterolemic rabbits. These
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Fig. 5. Methylation pattern of HpaII-MspI sites of rabbit LGALS3
in expressing and nonexpressing cell lines. A, upper part: Total cel-
lular DNAs from Rb-1 (lanes R1) and RCMV-5 (lanes R5) were di-
gested with MspI or HpaII and hybridized to the cloned NheI/Bam-
HI fragment containing about 2.4 kb of the 5P £anking region of
LGALS3. Lane P is the pattern obtained after cleavage of the NheI/
BamHI fragment with MspI. Lower part: Southern blotting of the
same DNA digested with PvuII. B: Distribution of the MspI/HpaII
sites along the 5P £anking region of rabbit LGALS3. The sites are
numbered from right to left starting from the site closest to exon 1.
+ and 3 respresent methylated and unmethylated sites respectively.
M and H stand for MspI and HpaII sites, respectively. The sizes of
the restriction fragments are indicated in bp.
Fig. 4. Transfection of LGALS3 cDNA in galectin-3 expressing and
non-expressing SMC. pPG3.10, a plasmid containing about 10 kb
of the 5P £anking region of rabbit LGALS3 upstream of the lucifer-
ase gene (gal-3 prom.), was transfected into Rb-1 (black bars) and
RCMV-5 cells (gray bars). The luciferase activity was expressed as
the percentage of that obtained in the reference experiment using
pSV2Luc (SV40 prom.), a plasmid containing the luciferase gene
under the control of the SV40 late promoter.
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lesions are rich in foam cells which derive partly from mono-
cytes/macrophages and partly from SMC [25]. Di¡erentiation
of monocytes to macrophages increases galectin-3 production
[26,27] by means of gene activation [28]. Consequently,
LGALS3 transcripts could be the result of expression in mac-
rophages and/or SMC.
Balloon catheter injury of artery is a model of accelerated
arteriosclerosis, which is more related to restenosis after an-
gioplasty than to atherosclerosis. However, this experimental
model is a well de¢ned system of SMC activation without any
de¢ned participation of monocytes/macrophages. Rat aortic
injury induces a ¢rst step of medial SMC proliferation.
DNA synthesis is maximal 2 days after treatment [13,14].
SMC migrate into the intima where their further proliferation
and the production of extracellular matrix components result
in de¢nite thickening of the intima. LGALS3 mRNA in-
creased with time and reached a plateau at late time points
when the intimal formation reaches a maximum [14]. These
results indicate that activated SMC can produce LGALS3
transcripts. It should be noted that a low level of LGALS3
expression is detected 2 days after angioplasty when medial
SMC are in active replication. At this early time point, the
number of activated cells is low compared to the total amount
of cells in the samples thus minimizing the e⁄ciency of detec-
tion.
Expression of LGALS3 transcripts is not detected in quies-
cent SMC from the media of normal vessels but raises a high
level in primary cultures. This activation is probably related to
a change in phenotype. SMC are in a contractile phenotype in
the normal vessel and acquire a synthetic or secretory pheno-
type in cultures or in atherosclerotic lesions. This is associated
with induction of a speci¢c set of genes [13]. Our results in-
dicate that LGALS3 belongs to this class of genes activated
during phenotypic modulation of SMC from the contractile to
the secretory state. Once activated, LGALS3 expression in
SMC appeared to be constitutive and independent of serum
concentration, a situation di¡erent from quiescent 3T3 cells in
which addition of serum factors increased the expression of
LGALS3 both at protein and mRNA levels [29]. This suggests
that regulation of LGALS3 may be dependent on the cell
type.
Most SMC established cell lines also expressed galectin-3. It
has been reported that SV40 transformed ¢broblasts ex-
pressed more lectin than their non-transformed counterparts
[30]. In SV40 transformed SMC lines, the level of LGALS3
transcripts is variable and not related to the rate of cell
growth (data not shown). In some cell lines transformed by
the morphological transforming region of human cytomega-
lovirus or HSV-2, expression of LGALS3 was completely
turned o¡. This appeared to be a stable character. The reason
for decreased expression of LGALS3 in these cells is not clear.
The cloned promoter was equally active in expressing and
non-expressing cells upon transfection of a reporter plasmid
containing 10 kb of DNA upstream of LGALS3. This rules
out the possibility that non-expressing cells lacked speci¢c
transcription factors. Also, no di¡erence was observed in the
methylation pattern of the GC rich region upstream of the
gene. Alternatively, non-expressing cells could produce a neg-
ative transcription factor. The binding element for such a
factor should be looked for in a region distant from the
gene. Another explanation could be that SMC expressing dif-
ferent phenotypes are present in the rabbit normal artery from
where these cell lines are derived. In the rat arterial wall, two
di¡erent phenotypes, designated Z and W, have been demon-
strated [13]. These phenotypes are stable and are maintained
in cultures upon successive passages. The isolation of clones
of transformed SMC expressing or non-expressing constitu-
tively LGALS3 could be related to the existence of such het-
erogeneity in the rabbit vessel wall.
The noticeable activation of LGALS3 gene in cells involved
in the development of atherosclerosis establishes a strong re-
lationship between the expression of this factor and the devel-
opment of plaques. While its precise function in atherosclero-
sis remains to be investigated, several lines of evidence suggest
that this lectin could play a role in control of cell adhesion.
Galectin-3 is considered a marker of macrophage di¡erentia-
tion. It is the major non-integrin laminin binding protein of
macrophages [3] and could play a role in extravasation and
tissue ¢xation of macrophages by modifying cell-cell and cell-
matrix interactions [2]. Our results suggest that activated SMC
may acquire speci¢c traits of macrophages. This may not be
surprising considering that SMC are known to express the
macrophage scavenger receptor which mediates uptake of
modi¢ed low density lipoproteins, a process thought to lead
to the transformation of SMC into foam cell formation [31].
More recently, the expression of another marker has been
described, the macrophage CD68 antigen in subendothelial
SMC of both normal and atheromatous human aortas [32].
Galectin-3 expression in SMC supports these observations.
Production of galectin-3 in SMC could act as an anti-adhesive
factor in reducing the interactions between integrins and ma-
trix glycoproteins thus facilitating their migration and prolif-
eration in the neointima.
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